Aqr Capital Management LLC Candel Therapeutics, Inc. Transaction History
Aqr Capital Management LLC
- $75.6 Billion
- Q4 2024
A detailed history of Aqr Capital Management LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 21,859 shares of CADL stock, worth $176,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,859
Previous 20,036
9.1%
Holding current value
$176,183
Previous $138,000
36.96%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CADL
# of Institutions
77Shares Held
15.6MCall Options Held
981KPut Options Held
521K-
Baker Bros. Advisors LP New York, NY2.98MShares$24 Million0.29% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.94MShares$15.6 Million9.1% of portfolio
-
Northpond Ventures, LLC1.94MShares$15.6 Million48.35% of portfolio
-
Braidwell LP Stamford, CT1.6MShares$12.9 Million0.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$10.8 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $233M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...